Cointime

NUVISAN GmbH

company

About

NUVISAN GmbH provides product development and support services to the pharmaceutical, biotechnology, and medical device industries.

  • Neu-ulm,Bayern,Germany
  • 1 - 10

Highlights

Total Funding Amount
$9.60M
Funding Rounds
1
Investors
1
Acquisition
1
Employee Profiles
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$9.60M
Industries
Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1979
Number Of Employee
1 - 10
Operating Status
Active
Also Known As
AAIPharma Deutschland GmbH & Co. KG

Nuvisan Pharma Services is a global provider of product development and
support services to the pharmaceutical, biotechnology and medical device
industries. We deliver services ranging from a single test to fully integrated
drug development programs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$9.60M
NUVISAN GmbH has raised a total of $9.60M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2022 Grant $9.60M 1 Bill & Melinda Gates Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NUVISAN GmbH is funded by 1 investors. Bill & Melinda Gates Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
Bill & Melinda Gates Foundation Yes Grant

Employee Profiles

Number of Employee Profiles
3
NUVISAN GmbH has 3 current employee profiles, including Executive Dietrich Bruchmann
Dietrich Bruchmann
Executive
Andreas Bender
Executive
Christoph Sachse
Executive

Acquisition

NUVISAN GmbH has acquired 1 organizations. Their most recent acquisition was Essex Pharma Development on Jun 1, 2011. They acquired Essex Pharma Development for 0.

Date Company Name
Industry Acquisition Type Price
Jun 1, 2011 Essex Pharma Development
Analytics acquisition — Detail
Cointime
เนื้อหา
บริษัท